On February 19, 2018 Improved Immune Responses in Young and Aged Mice with Adjuvanted Vaccines against H1N1 Influenza Infection
On April 21, 2017 A Formulated TLR7/8 Agonist is a Flexible, Highly Potent and Effective Adjuvant for Pandemic Influenza Vaccines
On February 1, 2012 GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults
On October 27, 2010 A synthetic adjuvant to enhance and expand immune responses to influenza vaccines
